Old Web
English
Sign In
Acemap
>
authorDetail
>
Feng Gao
Feng Gao
GlaxoSmithKline
Medicine
Placebo
Agonist
Endocrinology
Internal medicine
4
Papers
20
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Assessing the impact of Losmapimod on proteinuria in idiopathic focal segmental glomerulosclerosis
2020
Kidney International Reports
Debbie S. Gipson
Michelle A. Hladunewich
Richard A. Lafayette
John Sedor
Brad H. Rovin
Sean J. Barbour
Alan W. McMahon
J. Charles Jennette
Patrick H. Nachman
Robert N. Willette
Marcella G. Paglione
Feng Gao
Jorge Alfonso Ross Terres
Sue Vallow
M. Claire Holland
Kevin S. Thorneloe
Dennis L. Sprecher
Show All
Source
Cite
Save
Citations (3)
A Randomized, Placebo‐Controlled Trial to Assess the Effects of 8 Weeks of Administration of GSK256073, a Selective GPR109A Agonist, on High‐Density Lipoprotein Cholesterol in Subjects With Dyslipidemia
2019
Clinical pharmacology in drug development
Eric Olson
Kelly M. Mahar
Thomas F. Haws
Michael J. Fossler
Feng Gao
Anne-Charlotte de Gouville
Dennis L. Sprecher
John J. Lepore
Show All
Source
Cite
Save
Citations (1)
Immunogenicity and Safety of 3 Formulations of a Respiratory Syncytial Virus Candidate Vaccine in Nonpregnant Women: A Phase 2, Randomized Trial
2019
The Journal of Infectious Diseases
Tino F. Schwarz
Roderick A McPhee
Odile Launay
Geert Leroux-Roels
Jaak Talli
Marta Picciolato
Feng Gao
Rongman Cai
Thi Lien-Anh Nguyen
Ilse Dieussaert
Jacqueline M. Miller
Alexander C. Schmidt
Show All
Source
Cite
Save
Citations (4)
GSK256073 acutely regulates NEFA levels via HCA2 agonism but does not achieve durable glycaemic control in type 2 diabetes. A randomised trial.
2015
European Journal of Pharmacology
Robert L. Dobbins
Robert Byerly
Riley Gaddy
Feng Gao
Kelly M. Mahar
Antonella Napolitano
Philip Ambery
Anne-Charlotte de Gouville
Show All
Source
Cite
Save
Citations (12)
1